References
- Colizza K, Wang W, Davis J, Kamel A. (2008). Characterization of in vivo metabolites of the potent 5-HT1D receptor antagonist CP-448,187 in Sprague-Dawley rats by HPLC/RAM/ESI/MS/MS. The 56th ASMS Conference on Mass Spectrometry and allied topics, Denver, Colorado.
- Duan MJ, Yu L, Savanapridi C, Jacob P 3rd, Benowitz NL. (1991). Disposition kinetics and metabolism of nicotine-1’-N-oxide in rabbits. Drug Metab Dispos 19:667–672.
- Guryev OL, Gilep AA, Usanov SA, Estabrook RW. (2001). Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions. Biochemistry 40:5018–5031.
- Kamel A, Colizza K, Wang W. (2009). Characterization of the P450-Isozyme(s) Responsible For the Formation of 5-OH-CP-448,187 (M2) and N-oxide-CP-448,187 (M10) in Human Liver Microsomes by HPLC/ESI/MS/MS. The 57th ASMS Conference on Mass Spectrometry and allied topics, Philadelphia, PA.
- Kamel A, Obach RS, Colizza K, Wang W, O’Connell TN, Coelho RV Jr, Kelley RM, Schildknegt K. (2010). Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humans. Drug Metab Dispos 38:1984–1999.
- Kitamura S, Sugihara K, Tatsumi K. (1999). A unique tertiary amine N-oxide reduction system composed of quinone reductase and heme in rat liver preparations. Drug Metab Dispos 27:92–97.
- Kitamura S, Tatsumi K. (1984a). Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem Biophys Res Commun 120:602–606.
- Kitamura S, Tatsumi K. (1984b). Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase. Biochem Biophys Res Commun 121:749–754.
- Kuss HJ, Jungkunz G, Johannes KJ. (1985). Single oral dose pharmacokinetics of amitriptylinoxide and amitriptyline in humans. Pharmacopsychiatry 18:259–262.
- Omura T, Sato R. (1964). The carbon monoxide binding pigment of liver microsomes. J. Biol Chem 239:3137–3142.
- Prakash C, Kamel A, Cui D, Whalen RD, Miceli J, Tweedie D. (2001). Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. Br J Clin Pharmacol 49 (Suppl. 1):35S–42S.
- Rodrigues AD. (1999). Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem Pharmacol 57:465–480.
- Schenkman JB, Jansson I. (1999). Interactions between cytochrome P450 and cytochrome b5. Drug Metab Rev 31:351–364.
- Shet MS, Faulkner KM, Holmans PL, Fisher CW, Estabrook RW. (1995). The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein. Arch Biochem Biophys 318:314–321.
- Wang W, Colizza K, Kamel A. (2009). Characterization of in vivo metabolites of the potent 5-HT1D receptor antagonist CP-448,187 in mouse by HPLC/RAM/ESI/MS/MS. The 57th ASMS Conference on Mass Spectrometry and allied topics, Philadelphia, PA.
- Yamazaki H, Nakano M, Imai Y, Ueng YF, Guengerich FP, Shimada T. (1996a). Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch Biochem Biophys 325:174–182.
- Yamazaki H, Johnson WW, Ueng YF, Shimada T, Guengerich FP. (1996b). Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5. J Biol Chem 271:27438–27444.
- Yamazaki H, Shimada T, Martin MV, Guengerich FP. (2001). Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase. J Biol Chem 276:30885–30891.
- Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–337.